Predictors of disease progression in HIV infection: a review. - Wikidata - wikimedia - TriplyDB

Predictors of disease progression in HIV infection: a review.

Predictors of disease progression in HIV infection: a review.

http://www.wikidata.org/entity/Q35834337

about

Drug-class specific impact of antivirals on the reproductive capacity of HIV Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load HIV-1 diversity, transmission dynamics and primary drug resistance in Angola Extremely High Mutation Rate of HIV-1 In Vivo Simultaneously estimating evolutionary history and repeated traits phylogenetic signal: applications to viral and host phenotypic evolution Using drug exposure for predicting drug resistance - A data-driven genotypic interpretation tool Articulating a rights-based approach to HIV treatment and prevention interventions.Recent Insights into the HIV/AIDS Pandemic.The contribution of viral genotype to plasma viral set-point in HIV infection Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals.Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection.Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African women CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on antiretroviral therapy.Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C)Spatiotemporal dynamics of simian immunodeficiency virus brain infection in CD8+ lymphocyte-depleted rhesus macaques with neuroAIDS.Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb.Rapid disease progression in HIV-1 subtype C-infected South African women.Predictors of immunological failure of antiretroviral therapy among HIV infected patients in Ethiopia: a matched case-control study Recommendations for the follow-up of study participants with breakthrough HIV infections during HIV/AIDS biomedical prevention studies.Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.Factors related to changes in CD4+ T-cell counts over time in patients living with HIV/AIDS: a multilevel analysis.Cost analysis of pharmaceutical care provided to HIV-infected patients: an ambispective controlled study.Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria.Comparing Measures of Late HIV Diagnosis in Washington State.Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa Disease progression of HIV-1 infection in symptomatic and asymptomatic seroconverters in Osaka, Japan: a retrospective observational study.Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.Pattern and predictors of immunologic recovery in HIV infected patients.A non-specific biomarker of disease activity in HIV/AIDS patients from resource-limited environments.HIV type 1 mutational patterns in HIV type 1 subtype C-infected long-term survivors in Karonga District Malawi: further analysis and correction.Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rate Individual and neighborhood predictors of mortality among HIV-positive Latinos with history of injection drug use, Florida, 2000-2011.Prevalence of drug resistance and associated mutations in a population of Hiv-1+ Puerto Ricans in 2005.A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge Expression of interleukin-15 and interleukin-15Rα in monocytes of HIV type 1-infected patients with different courses of disease progression.HIV-1 molecular epidemiology among newly diagnosed HIV-1 individuals in Hebei, a low HIV prevalence province in China.Survival of people living with HIV who defaulted from tuberculosis treatment in a cohort, Recife, Brazil.

P2860

Q28473451-1860530C-DD2F-4085-8F1C-5F1803E028E7 Q28475652-F2C4CF0B-59C2-40CD-A356-B6701C7AD44B Q28542528-8E7FC667-6ED3-450D-A583-2BFB6C279802 Q28548089-46B259FF-07AB-497F-B13B-743F8C722F11 Q28652426-E9F135DB-1E25-412A-88F9-B2A228ADE147 Q30000270-30A42E25-5EC3-4106-A10F-D645B081FDCB Q30224939-7EEBB489-A6EB-4A0E-81AC-67CD976E1231 Q30235024-59EB972A-A230-4FFD-A201-C7680C2B0F8D Q33553778-0E64C40A-35A0-4D8D-8EDB-8F140C08EAED Q33654674-35CEA4EC-CA4C-4464-BF92-17A9673FF2CC Q33828507-ACCE5E0C-4287-4895-A7D1-E0150E5D4061 Q34034101-2136D4AD-3D72-4DF1-A1E2-B66BE17B8BCC Q34138834-F6D70F5E-0B12-498B-9F95-B71B47077649 Q34195328-BE20DDB4-C04F-40ED-AE58-0ED2BC036A89 Q34466498-672E7918-1034-497D-965A-D0A095932654 Q34474434-A693F5BC-B4DA-49AA-9A59-B6AEF52816CF Q34520599-35DEA3E1-0103-4C5F-8581-B71D7B388A91 Q34714799-6675B0F3-7B61-4E2F-8AE4-C4242A561875 Q34736181-112E47D3-DF66-4A68-9550-D186C5EBA86C Q34764695-C88620DD-33BF-4B77-B6C3-674FD0DE75C0 Q34858876-D657F779-0B18-4366-BAD2-21436FC74F4D Q35076519-09137B68-5150-4C2D-AEAA-A7DA2C4D24C9 Q35088030-8A663387-2C30-496A-97FD-A694A9191B8D Q35102751-64302C5D-9F8B-46CA-9532-3258026E4C09 Q35122039-910943F7-CB91-41AC-92C0-5AB0A8FB0B44 Q35560631-8CFFB7A8-83ED-41F0-8B54-9DCC34F18BE6 Q35579479-AE6134D5-D1C2-4C47-ACD9-B00AC81FF4DD Q35632074-06D150B5-8234-424E-9737-C8102FA32441 Q35633636-85080C2C-CFEF-48EC-9660-C7A12C7F5513 Q35758499-49A0E4DA-62DB-40CB-BED1-AEC00BC1B5FC Q35765115-5BD654BF-6948-40FE-8102-4031F30D0113 Q35780654-6E2A7DAB-CE1E-4E73-850E-7311E342187D Q35799135-EAF8C81A-5900-45FD-8D15-06A55450BD21 Q35842723-C4D3B3C6-DF0D-4C14-A806-4C237120EDF7 Q35952168-E007BFEC-422A-4188-A8F7-56B2D318272F Q36016153-EB9777BC-FF4C-4E93-8989-B7500047D33E Q36024470-6904BDC0-6DEF-43F9-8790-B64AFE5A1C72 Q36050117-BF9ABB27-F9CA-4B1F-875C-D3ECB99CD929 Q36274394-0F9096D9-7193-4E25-AF7A-47639C562BF0 Q36277404-89E1B2F2-2879-4615-AE4C-F92A8812A6A2

P2860

Predictors of disease progression in HIV infection: a review.

http://www.wikidata.org/entity/Q35834337

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Predictors of disease progression in HIV infection: a review.

@ast

Predictors of disease progression in HIV infection: a review.

@en

type

label

Predictors of disease progression in HIV infection: a review.

@ast

Predictors of disease progression in HIV infection: a review.

@en

prefLabel

Predictors of disease progression in HIV infection: a review.

@ast

Predictors of disease progression in HIV infection: a review.

@en

P1433

Q35834337-47D715A8-D625-429E-8FB2-BFDDF2C65B92

P1476

Q35834337-0D0F4662-B722-403D-9C8E-33A27B38C95D

P2093

Q35834337-26ADE27F-31C8-4983-8EF9-DE4BE517F7FE

Q35834337-C6467B13-28C0-4364-9282-8E9CA3B380B5

P2860

Q35834337-0240329F-8AC0-4145-BAAC-93A5D702A856

Q35834337-08B8EFF1-8C8C-419D-AF80-3FB3D65ED8BB

Q35834337-0A538680-8DBD-4705-A1C3-6B2236EFAA9D

Q35834337-0C2E6637-D68A-4F19-9264-6459C44F2D92

Q35834337-10BE7A3D-E838-4973-B66B-5B0FE9C86DC4

Q35834337-124C4A54-2CB7-453A-9954-830A1DCC8231

Q35834337-13DD4FE6-A085-4A2D-8AFA-4C6BA6232FDF

Q35834337-1431CA33-49E6-4D62-9C1B-6494C859316E

Q35834337-15D91976-DB04-4F25-A546-0093600A1061

Q35834337-177D44C5-DB4C-4283-9EE5-DDB8B015352C

P2888

Q35834337-7F75BC7C-084A-44FA-BF12-D06CBFA00A36

P304

Q35834337-A7CB596B-7A27-4DBA-A6FF-F354A3807305

P31

Q35834337-CFEAA267-3034-4CA2-B067-E76283CCB835

P356

Q35834337-0159FEA4-04F3-4C06-9C0E-D49458225F78

P478

Q35834337-87A8ECF8-B6EE-4D33-8F10-92647A411EED

P50

Q35834337-06CB0422-7493-42B1-B66A-0CB363B8D20D

P577

Q35834337-505E2A10-B146-461B-9F3B-110FD2EA6BDF

P5875

Q35834337-0DED385A-D041-4EB0-87B2-109C3EA6F865

P6179

Q35834337-FA072FB6-5739-4AF8-99FF-EBB7345B22D8

P698

Q35834337-D8CA1F1E-8AC7-413B-B472-A33400F6F211

P932

Q35834337-D687F1DF-0B21-479D-AE14-C068265C874B

P356

P1433

AIDS Research and Therapy

P1476

Predictors of disease progression in HIV infection: a review.

@en

P2093

David A Cooper

http://www.w3.org/2001/XMLSchema#string

Simone E Langford

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda

HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.

Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape.

Natural history of HIV infection in the era of combination antiretroviral therapy.

Determinants of virological response to antiretroviral therapy: implications for long-term strategies.

Molecular virology and immunology of HIV infection.

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.

P2888

P304

11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-6405-4-11

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Jintanat Ananworanich

P577

2007-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6330140

http://www.w3.org/2001/XMLSchema#string

P6179

1010604744

http://www.w3.org/2001/XMLSchema#string

P698

17502001

http://www.w3.org/2001/XMLSchema#string

P932

1887539

http://www.w3.org/2001/XMLSchema#string